タンパク質発現市場の市場規模、シェア、動向分析レポート：発現システム別（原核生物、哺乳類細胞）、製品別（試薬、コンピテントセル）、アプリケーション別（治療、産業）、最終用途別、セグメント予測、2023年～2030年

タンパク質発現市場の成長と動向

Grand View Research, Inc.の最新レポートによると、世界のタンパク質発現市場規模は2030年までに66億4,000万米ドルに達し、2023年から2030年までのCAGRは9.36％で拡大すると予測されています。

プロテオミクスとゲノミクスの調査の増加、慢性疾患の罹患率の上昇、世界中で高まる生物学的製剤の需要が、タンパク質発現の需要を高めており、これが市場を牽引する可能性が高いです。例えば、2022年4月、Frontiers Media S.A.に掲載された調査では、研究者は多発性硬化症（MS）の潜在的な診断バイオマーカーを特定するために22のタンパク質を差次的に発現させました。

各社による研究開発投資の増加は、タンパク質発現の利用にかなりの影響を与えると推定されます。2022年8月、Biocon Biologicsのマネージング・ディレクターはあるインタビューの中で、研究開発にかかる総コストは収益の12～14％であると述べた。この投資は、約20のバイオシミラー分子からなる持続可能なポートフォリオを構築するために不可欠であり、同社は少なくとも1～2年に1回は上市すると予想されています。これらの分子開発にかかるおおよそのコストは5,000万～1億米ドルです。

タンパク質治療薬に対する需要の急加速や、タンパク質発現産業の応用に対する政府の投資など、その他の決定要因も市場の成長を支えています。例えば、2022年5月、プロテオミクス・インターナショナル・ラボラトリーズは、医療研究未来基金（MRFF）イニシアチブの下、オーストラリア政府から約286,833米ドルの資金を獲得しました。この資金は、オーストラリアにおけるPromarkerD検査の製造を支援するものと期待されています。このような資金援助は、今後数年間の市場成長を補完するものと思われます。

COVID-19パンデミックの発生により、COVID-19患者のプロファイリングと遺伝子発現の差分解析を実施しようという衝動が高まっています。2021年3月、Briefings in Bioinformaticsに掲載された調査では、COVID-19の治療薬を特定するためにタンパク質-薬物相互作用のデータが用いられました。その結果、このプロセスの利用はCOVID-19の流行期に急増し、市場成長に寄与すると予測されます。

個別化治療とワクチンに対する要求の高まりは、予測期間中の市場成長を促進する主要因になると予想されます。例えば、2022年1月、Amgen社はGenerate Biomedicines社との提携を発表し、様々な分野のタンパク質治療薬を発見・開発しています。両社はこの提携の価値を約19億米ドルと見積もっています。

食品や飲食品の生産など産業アプリケーションでの組換えタンパク質の開発が増加していることから、ヘルスケア以外の分野でのタンパク質発現の利用が促進されると予想されます。しかし、工業用と医薬品用の組換えタンパク質の小売価格は大きく異なり、医薬品用タンパク質は1kgあたり数十億米ドルで販売されているのに対し、工業用タンパク質は1kgあたり数十ドルです。医薬品用タンパク質には、研究開発、臨床試験、特許が追加で必要となります。

タンパク質発現市場レポートハイライト

• 発現システム別では、原核生物セグメントが2022年に最大のシェアを占めました。研究者の間でこのシステムの使用率が高いのは、生物学的に活性なタンパク質を短時間で大量に生産できるためです。
• 製品別では、サービス分野が予測期間中に有利な成長を遂げると予測されています。CROへのアウトソーシングの増加やヘルスケア以外の分野での組換えタンパク質需要の増加が、このセグメントの成長を後押ししています。
• アプリケーション別では、治療分野が2022年の市場を独占しました。この背景には、研究開発投資の増加や資金調達などの戦略的な取り組みがあります。
• 最終用途別では、慢性疾患に対する生物製剤の需要が高まっていることから、製薬企業およびバイオテクノロジー企業が2022年に最大の収益シェアを占めました。
• 北米は、この地域での多額の研究開発投資の存在に加え、新興企業への資金調達機会の利用可能性により、2022年の世界市場で優位を占めました。

目次

第1章 調査手法と範囲

• 市場セグメンテーションと範囲
  • セグメントの定義
• 情報調達
  • 市場の形成とデータの視覚化
  • データの検証と公開
• 調査の仮定
• 調査手法
  • 購入したデータベース
  • Gvrの内部データベース
  • 二次情報
  • 1次調査
  • 1次調査の詳細
• 情報またはデータ分析
  • データ分析モデル
• 市場の形成と検証
• モデル詳細
  • 商品フロー分析
• 二次情報のリスト
• 世界市場：CAGRの計算
• 目的

第2章 エグゼクティブサマリー

• 市場スナップショット
• セグメントのスナップショット
• 競合情勢のスナップショット

第3章 タンパク質発現市場の変数と動向

• 市場系統の見通し
  • 親市場の見通し
  • 関連/補助的な市場見通し
• 市場力学
  • 市場促進要因の影響分析
  • 市場抑制の影響分析
• 業界分析ツール

第4章 タンパク質発現システムのビジネス分析

• タンパク質発現市場：発現システムの変動分析
• 原核生物の発現システム
  • 原核生物発現システム市場、2018～2030年（100万米ドル）
• 哺乳類細胞発現システム
  • 哺乳類細胞発現システム市場、2018年～2030年（100万米ドル）
• 昆虫細胞発現システム
  • 昆虫細胞発現システム市場、2018年～2030年（100万米ドル）
• 酵母発現システム
  • 酵母発現システム市場、2018～2030年（100万米ドル）
• その他の発現システム
  • その他の発現システム市場、2018-2030（100万米ドル）

第5章 製品ビジネス分析

• タンパク質発現市場：製品の変動分析
• 試薬
  • 試薬市場、2018-2030（100万米ドル）
• コンピテントセル
  • コンピテントセル市場、2018年～2030年（100万米ドル）
• 発現ベクター
  • 発現ベクター市場、2018-2030（100万米ドル）
• サービス
  • サービス市場、2018～2030年（100万米ドル）
• 機器
  • 機器市場、2018-2030（100万米ドル）

第6章 アプリケーションビジネス分析

• タンパク質発現市場：アプリケーションの変動分析
• 治療への応用
  • 治療アプリケーション市場、2018～2030年（100万米ドル）
• 産業アプリケーション
  • 産業アプリケーション市場、2018～2030年（100万米ドル）
• 調査アプリケーション
  • 調査アプリケーション市場、2018～2030年（100万米ドル）

第7章 最終用途ビジネス分析

• タンパク質発現市場：最終用途の変動分析
• 製薬会社およびバイオテクノロジー会社
  • 製薬およびバイオテクノロジー企業の市場、2018～2030年（100万米ドル）
• 学術調査
  • 学術調査市場、2018年～2030年（100万米ドル）
• 受託調査機関
  • 受託調査機関市場、2018年～2030年（100万米ドル）

第8章 地域ビジネス分析

• 地域別タンパク質発現市場シェア、2022年および2030年
• 北米
  • 北米のタンパク質発現市場、2018-2030（100万米ドル）
  • 米国
  • カナダ
• 欧州
  • 欧州のタンパク質発現市場、2018-2030（100万米ドル）
  • 英国
  • ドイツ
  • フランス
  • イタリア
  • スペイン
  • デンマーク
  • スウェーデン
  • ノルウェー
• アジア太平洋地域
  • アジア太平洋地域のタンパク質発現市場、2018～2030年（100万米ドル）
  • 日本
  • 中国
  • インド
  • オーストラリア
  • タイ
  • 韓国
• ラテンアメリカ
  • ラテンアメリカのタンパク質発現市場、2018-2030（100万米ドル）
  • ブラジル
  • メキシコ
  • アルゼンチン
• MEA
  • MEAのタンパク質発現市場、2018年～2030年（100万米ドル）
  • 南アフリカ
  • サウジアラビア
  • アラブ首長国連邦
  • クウェート

第9章 競合情勢

• 会社の分類
• 戦略マッピング
• 企業の市場シェア分析、2022年
• 企業プロファイル・一覧表
  • Agilent Technologies, Inc
  • QIAGEN
  • Thermo Fisher Scientific, Inc.
  • Merck KGaA
  • Bio-Rad Laboratories, Inc.
  • Promega Corporation
  • New England Biolabs
  • Takara Bio, Inc.
  • Oxford Expression Technologies
  • Lucigen Corporation

List of Tables

• Table 1 List of Secondary Sources
• Table 2 List of Abbreviations
• Table 3 Global Protein Expression Market, by Expression systems, 2018 - 2030 (USD Million)
• Table 4 Global Protein Expression Market, by Products, 2018 - 2030 (USD Million)
• Table 5 Global Protein Expression Market, by Application, 2018 - 2030 (USD Million)
• Table 6 Global Protein Expression Market, End-use, 2018 - 2030 (USD Million)
• Table 7 Global Protein Expression Market, by Region, 2018 - 2030 (USD Million)
• Table 8 North America Protein Expression Market, by Country, 2018 - 2030 (USD Million)
• Table 9 North America Protein Expression Market, by Expression systems, 2018 - 2030 (USD Million)
• Table 10 North America Protein Expression Market, by Products, 2018 - 2030 (USD Million)
• Table 11 North America Protein Expression Market, by Application, 2018 - 2030 (USD Million)
• Table 12 North America Protein Expression Market, End-use, 2018 - 2030 (USD Million)
• Table 13 U.S. Protein Expression Market, by Expression systems, 2018 - 2030 (USD Million)
• Table 14 U.S. Protein Expression Market, by Products, 2018 - 2030 (USD Million)
• Table 15 U.S. Protein Expression Market, by Application, 2018 - 2030 (USD Million)
• Table 16 U.S. Protein Expression Market, End-use, 2018 - 2030 (USD Million)
• Table 17 Canada Protein Expression Market, by Expression systems, 2018 - 2030 (USD Million)
• Table 18 Canada Protein Expression Market, by Products, 2018 - 2030 (USD Million)
• Table 19 Canada Protein Expression Market, by Application, 2018 - 2030 (USD Million)
• Table 20 Canada Protein Expression Market, End-use, 2018 - 2030 (USD Million)
• Table 21 Europe Protein Expression Market, by Country, 2018 - 2030 (USD Million)
• Table 22 Europe Protein Expression Market, by Expression systems, 2018 - 2030 (USD Million)
• Table 23 Europe Protein Expression Market, by Products, 2018 - 2030 (USD Million)
• Table 24 Europe Protein Expression Market, by Application, 2018 - 2030 (USD Million)
• Table 25 Europe Protein Expression Market, End-use, 2018 - 2030 (USD Million)
• Table 26 Germany Protein Expression Market, by Expression systems, 2018 - 2030 (USD Million)
• Table 27 Germany Protein Expression Market, by Products, 2018 - 2030 (USD Million)
• Table 28 Germany Protein Expression Market, by Application, 2018 - 2030 (USD Million)
• Table 29 Germany Protein Expression Market, End-use, 2018 - 2030 (USD Million)
• Table 30 UK Protein Expression Market, by Expression systems, 2018 - 2030 (USD Million)
• Table 31 UK Protein Expression Market, by Products, 2018 - 2030 (USD Million)
• Table 32 UK Protein Expression Market, by Application, 2018 - 2030 (USD Million)
• Table 33 UK Protein Expression Market, End-use, 2018 - 2030 (USD Million)
• Table 34 France Protein Expression Market, by Expression systems, 2018 - 2030 (USD Million)
• Table 35 France Protein Expression Market, by Products, 2018 - 2030 (USD Million)
• Table 36 France Protein Expression Market, by Application, 2018 - 2030 (USD Million)
• Table 37 France Protein Expression Market, End-use, 2018 - 2030 (USD Million)
• Table 38 Italy Protein Expression Market, by Expression systems, 2018 - 2030 (USD Million)
• Table 39 Italy Protein Expression Market, by Products, 2018 - 2030 (USD Million)
• Table 40 Italy Protein Expression Market, by Application, 2018 - 2030 (USD Million)
• Table 41 Italy Protein Expression Market, End-use, 2018 - 2030 (USD Million)
• Table 42 Spain Protein Expression Market, by Expression systems, 2018 - 2030 (USD Million)
• Table 43 Spain Protein Expression Market, by Products, 2018 - 2030 (USD Million)
• Table 44 Spain Protein Expression Market, by Application, 2018 - 2030 (USD Million)
• Table 45 Spain Protein Expression Market, End-use, 2018 - 2030 (USD Million)
• Table 46 Denmark Protein Expression Market, by Expression systems, 2018 - 2030 (USD Million)
• Table 47 Denmark Protein Expression Market, by Products, 2018 - 2030 (USD Million)
• Table 48 Denmark Expression Market, by Application, 2018 - 2030 (USD Million)
• Table 49 Denmark Expression Market, End-use, 2018 - 2030 (USD Million)
• Table 50 Sweden Protein Expression Market, by Expression systems, 2018 - 2030 (USD Million)
• Table 51 Sweden Protein Expression Market, by Products, 2018 - 2030 (USD Million)
• Table 52 Sweden Expression Market, by Application, 2018 - 2030 (USD Million)
• Table 53 Sweden Expression Market, End-use, 2018 - 2030 (USD Million)
• Table 54 Norway Protein Expression Market, by Expression systems, 2018 - 2030 (USD Million)
• Table 55 Norway Protein Expression Market, by Products, 2018 - 2030 (USD Million)
• Table 56 Norway Expression Market, by Application, 2018 - 2030 (USD Million)
• Table 57 Norway Expression Market, End-use, 2018 - 2030 (USD Million)
• Table 58 Asia Pacific Protein Expression Market, by Country, 2018 - 2030 (USD Million)
• Table 59 Asia Pacific Protein Expression Market, by Expression systems, 2018 - 2030 (USD Million)
• Table 60 Asia Pacific Protein Expression Market, by Products, 2018 - 2030 (USD Million)
• Table 61 Asia Pacific Protein Expression Market, by Application, 2018 - 2030 (USD Million)
• Table 62 Asia Pacific Protein Expression Market, End-use, 2018 - 2030 (USD Million)
• Table 63 China Protein Expression Market, by Expression systems, 2018 - 2030 (USD Million)
• Table 64 China Protein Expression Market, by Products, 2018 - 2030 (USD Million)
• Table 65 China Protein Expression Market, by Application, 2018 - 2030 (USD Million)
• Table 66 China Protein Expression Market, End-use, 2018 - 2030 (USD Million)
• Table 67 Japan Protein Expression Market, by Expression systems, 2018 - 2030 (USD Million)
• Table 68 Japan Protein Expression Market, by Products, 2018 - 2030 (USD Million)
• Table 69 Japan Protein Expression Market, by Application, 2018 - 2030 (USD Million)
• Table 70 Japan Protein Expression Market, End-use, 2018 - 2030 (USD Million)
• Table 71 India Protein Expression Market, by Expression systems, 2018 - 2030 (USD Million)
• Table 72 India Protein Expression Market, by Products, 2018 - 2030 (USD Million)
• Table 73 India Protein Expression Market, by Application, 2018 - 2030 (USD Million)
• Table 74 India Protein Expression Market, End-use, 2018 - 2030 (USD Million)
• Table 75 South Korea Protein Expression Market, by Expression systems, 2018 - 2030 (USD Million)
• Table 76 South Korea Protein Expression Market, by Products, 2018 - 2030 (USD Million)
• Table 77 South Korea Protein Expression Market, by Application, 2018 - 2030 (USD Million)
• Table 78 South Korea Protein Expression Market, End-use, 2018 - 2030 (USD Million)
• Table 79 Australia Protein Expression Market, by Expression systems, 2018 - 2030 (USD Million)
• Table 80 Australia Protein Expression Market, by Products, 2018 - 2030 (USD Million)
• Table 81 Australia Protein Expression Market, by Application, 2018 - 2030 (USD Million)
• Table 82 Australia Protein Expression Market, End-use, 2018 - 2030 (USD Million)
• Table 83 Thailand Protein Expression Market, by Expression systems, 2018 - 2030 (USD Million)
• Table 84 Thailand Protein Expression Market, by Products, 2018 - 2030 (USD Million)
• Table 85 Thailand Protein Expression Market, by Application, 2018 - 2030 (USD Million)
• Table 86 Thailand Protein Expression Market, End-use, 2018 - 2030 (USD Million)
• Table 87 Latin America Protein Expression Market, by Country, 2018 - 2030 (USD Million)
• Table 88 Latin America Protein Expression Market, by Expression systems, 2018 - 2030 (USD Million)
• Table 89 Latin America Protein Expression Market, by Products, 2018 - 2030 (USD Million)
• Table 90 Latin America Protein Expression Market, by Application, 2018 - 2030 (USD Million)
• Table 91 Latin America Protein Expression Market, End-use, 2018 - 2030 (USD Million)
• Table 92 Brazil Protein Expression Market, by Expression systems, 2018 - 2030 (USD Million)
• Table 93 Brazil Protein Expression Market, by Products, 2018 - 2030 (USD Million)
• Table 94 Brazil Protein Expression Market, by Application, 2018 - 2030 (USD Million)
• Table 95 Brazil Protein Expression Market, End-use, 2018 - 2030 (USD Million)
• Table 96 Mexico Protein Expression Market, by Expression systems, 2018 - 2030 (USD Million)
• Table 97 Mexico Protein Expression Market, by Products, 2018 - 2030 (USD Million)
• Table 98 Mexico Protein Expression Market, by Application, 2018 - 2030 (USD Million)
• Table 99 Mexico Protein Expression Market, End-use, 2018 - 2030 (USD Million)
• Table 100 Argentina Protein Expression Market, by Expression systems, 2018 - 2030 (USD Million)
• Table 101 Argentina Protein Expression Market, by Products, 2018 - 2030 (USD Million)
• Table 102 Argentina Protein Expression Market, by Application, 2018 - 2030 (USD Million)
• Table 103 Argentina Protein Expression Market, End-use, 2018 - 2030 (USD Million)
• Table 104 Middle East & Africa Protein Expression Market, by Country, 2018 - 2030 (USD Million)
• Table 105 Middle East & Africa Protein Expression Market, by Expression systems, 2018 - 2030 (USD Million)
• Table 106 Middle East & Africa Protein Expression Market, by Products, 2018 - 2030 (USD Million)
• Table 107 Middle East & Africa Protein Expression Market, by Application, 2018 - 2030 (USD Million)
• Table 108 Middle East & Africa Protein Expression Market, End-use, 2018 - 2030 (USD Million)
• Table 109 South Africa Protein Expression Market, by Expression systems, 2018 - 2030 (USD Million)
• Table 110 South Africa Protein Expression Market, by Products, 2018 - 2030 (USD Million)
• Table 111 South Africa Protein Expression Market, by Application, 2018 - 2030 (USD Million)
• Table 112 South Africa Protein Expression Market, End-use, 2018 - 2030 (USD Million)
• Table 113 Saudi Arabia Protein Expression Market, by Expression systems, 2018 - 2030 (USD Million)
• Table 114 Saudi Arabia Protein Expression Market, by Products, 2018 - 2030 (USD Million)
• Table 115 Saudi Arabia Protein Expression Market, by Application, 2018 - 2030 (USD Million)
• Table 116 Saudi Arabia Protein Expression Market, End-use, 2018 - 2030 (USD Million)
• Table 117 UAE Protein Expression Market, by Expression systems, 2018 - 2030 (USD Million)
• Table 118 UAE Protein Expression Market, by Products, 2018 - 2030 (USD Million)
• Table 119 UAE Protein Expression Market, by Application, 2018 - 2030 (USD Million)
• Table 120 UAE Protein Expression Market, End-use, 2018 - 2030 (USD Million)
• Table 121 Kuwait Protein Expression Market, by Expression systems, 2018 - 2030 (USD Million)
• Table 122 Kuwait Protein Expression Market, by Products, 2018 - 2030 (USD Million)
• Table 123 Kuwait Protein Expression Market, by Application, 2018 - 2030 (USD Million)
• Table 124 Kuwait Protein Expression Market, End-use, 2018 - 2030 (USD Million)

List of Figures

• Fig. 1 Market research process
• Fig. 2 Information Procurement
• Fig. 3 Primary Research Pattern
• Fig. 4 Market Research Approaches
• Fig. 5 Value Chain-Based Sizing & Forecasting
• Fig. 6 Market Formulation & Validation
• Fig. 7 Global Protein Expression, Market Segmentation
• Fig. 8 Market Snapshot, 2022
• Fig. 9 Market Trends & Outlook
• Fig. 10 Market Driver Relevance Analysis (Current & Future Impact)
• Fig. 11 Market Restraint Relevance Analysis (Current & Future Impact)
• Fig. 12 Market Challenge Relevance Analysis (Current & Future Impact)
• Fig. 13 SWOT Analysis, By Factor (Political & Legal, Economic and Technological)
• Fig. 14 Porter's Five Forces Analysis
• Fig. 15 Market Penetration Vs Growth Prospect Mapping, 2022
• Fig. 16 Global Protein Expression Market: Expression systems Movement Analysis
• Fig. 17 Global Protein Expression Market, for Prokaryotic, 2018 - 2030 (USD Million)
• Fig. 18 Global Protein Expression Market, for Mammalian cell, 2018 - 2030 (USD Million)
• Fig. 19 Global Protein Expression Market, for Insect cell, 2018 - 2030 (USD Million)
• Fig. 20 Global Protein Expression Market, for Yeast, 2018 - 2030 (USD Million)
• Fig. 21 Global Protein Expression Market, for Others, 2018 - 2030 (USD Million)
• Fig. 22 Global Protein Expression Market: Product Movement Analysis
• Fig. 23 Global Protein Expression Market for Reagents, 2018 - 2030 (USD Million)
• Fig. 24 Global Protein Expression Market, for Competent cells, 2018 - 2030 (USD Million)
• Fig. 25 Global Protein Expression Market, for Expression vectors, 2018 - 2030 (USD Million)
• Fig. 26 Global Protein Expression Market, for Services, 2018 - 2030 (USD Million)
• Fig. 27 Global Protein Expression Market for Instruments, 2018 - 2030 (USD Million)
• Fig. 28 Global Protein Expression Market: Application Movement Analysis
• Fig. 29 Global Protein Expression Market, for Therapeutic, 2018 - 2030 (USD Million)
• Fig. 30 Global Protein Expression Market, for Industrial, 2018 - 2030 (USD Million)
• Fig. 31 Global Protein Expression Market, for Research, 2018 - 2030 (USD Million)
• Fig. 32 Global Protein Expression Market: End Use Movement Analysis
• Fig. 33 Global Protein Expression Market, for Pharmaceutical and biotechnological companies, 2018 - 2030 (USD Million)
• Fig. 34 Global Protein Expression Market, for Academic research, 2018 - 2030 (USD Million)
• Fig. 35 Global Protein Expression Market, for Contract research organizations, 2018 - 2030 (USD Million)
• Fig. 36 Global Protein Expression Market, for Others, 2018 - 2030 (USD Million)
• Fig. 37 Regional Marketplace: Key Takeaways
• Fig. 38 Regional Outlook, 2022 & 2030
• Fig. 39 Global Protein Expression Market: Region Movement Analysis
• Fig. 40 North America Protein Expression Market, 2018 - 2030 (USD Million)
• Fig. 41 U.S. Protein Expression Market, 2018 - 2030 (USD Million)
• Fig. 42 Canada Protein Expression Market, 2018 - 2030 (USD Million)
• Fig. 43 Europe Protein Expression Market, 2018 - 2030 (USD Million)
• Fig. 44 Germany Protein Expression Market, 2018 - 2030 (USD Million)
• Fig. 45 UK Protein Expression Market, 2018 - 2030 (USD Million)
• Fig. 46 France Protein Expression Market, 2018 - 2030 (USD Million)
• Fig. 47 Italy Protein Expression Market, 2018 - 2030 (USD Million)
• Fig. 48 Spain Protein Expression Market, 2018 - 2030 (USD Million)
• Fig. 49 Denmark Protein Expression Market, 2018 - 2030 (USD Million)
• Fig. 50 Sweden Protein Expression Market, 2018 - 2030 (USD Million)
• Fig. 51 Norway Protein Expression Market, 2018 - 2030 (USD Million)
• Fig. 52 Asia Pacific Protein Expression Market, 2018 - 2030 (USD Million)
• Fig. 53 Japan Protein Expression Market, 2018 - 2030 (USD Million)
• Fig. 54 China Protein Expression Market, 2018 - 2030 (USD Million)
• Fig. 55 India Protein Expression Market, 2018 - 2030 (USD Million)
• Fig. 56 Australia Protein Expression Market, 2018 - 2030 (USD Million)
• Fig. 57 South Korea Protein Expression Market, 2018 - 2030 (USD Million)
• Fig. 58 Thailand Protein Expression Market, 2018 - 2030 (USD Million)
• Fig. 59 Latin America Protein Expression Market, 2018 - 2030 (USD Million)
• Fig. 60 Brazil Protein Expression Market, 2018 - 2030 (USD Million)
• Fig. 61 Mexico Protein Expression Market, 2018 - 2030 (USD Million)
• Fig. 62 Argentina Protein Expression Market, 2018 - 2030 (USD Million)
• Fig. 63 Middle East and Africa Protein Expression Market, 2018 - 2030 (USD Million)
• Fig. 64 South Africa Protein Expression Market, 2018 - 2030 (USD Million)
• Fig. 65 Saudi Arabia Protein Expression Market, 2018 - 2030 (USD Million)
• Fig. 66 UAE Protein Expression Market, 2018 - 2030 (USD Million)
• Fig. 67 Kuwait Protein Expression Market, 2018 - 2030 (USD Million)

Protein Expression Market Growth & Trends

The global protein expression market size is expected to reach USD 6.64 billion by 2030, according to a new report by Grand View Research, Inc., expanding at a CAGR of 9.36% from 2023 to 2030. The increasing research in proteomics and genomics, the rising incidence of chronic diseases, and escalating demand for biologic products around the globe are enhancing the demand for protein expression, which is likely to drive the market. For instance, in April 2022, in a research published on Frontiers Media S.A., researchers differentially expressed 22 proteins to identify potential diagnostic biomarkers for Multiple Sclerosis (MS).

An increase in R&D investments by the players is estimated to have a considerable impact on the usage of protein expression. In August 2022, the managing director of Biocon Biologics stated in one of his interviews that the overall cost of the R&D is 12-14% of revenues. The investment is essential to build a sustainable portfolio of around 20 biosimilar molecules and the company is anticipated to launch at least once every 1-2 years. The approximate cost of developing these molecules is USD 50-100 million.

Other determinants such as rapid acceleration in the demand for protein therapeutics and government investment in the applications of the protein expression industry are also supporting the market growth. For instance, in May 2022, Proteomics International Laboratories was awarded approximately USD 286,833 funding from the Australian Government under the Medical Research Future Fund (MRFF) initiative. The funding is expected to support the manufacturing of the PromarkerD test in Australia. Such financial assistances are likely to supplement the market growth in the coming years.

The outbreak of the COVID-19 pandemic developed the urge to profile and conduct differential gene expression analyses on COVID-19 patients. Research published in Briefings in Bioinformatics, March 2021, employed the data of protein-drug interaction to identify the prospective drugs for COVID-19. As a result, the usage of the process is projected to upsurge during the COVID-19 pandemic and contribute to market growth.

The growing requirement for personalized therapy and vaccine is expected to be the key factor fueling the market growth during the forecast period. For instance, in January 2022, Amgen announced a collaboration with Generate Biomedicines to discover and develop protein therapeutics for various areas. The companies are estimating the worth of this collaboration around USD 1.9 billion.

The increasing development of recombinant proteins for industrial use, such as the production of food and beverages, is anticipated to boost the use of protein expression in the non-healthcare sector. However, the retail pricings of recombinant proteins for industrial and pharmaceutical uses are drastically different as pharmaceutical proteins are sold for billions of dollars per kg, while industrial proteins for tens of dollars per kg. R&D, clinical trials, and patents are the additional requirements of pharmaceutical proteins.

Protein Expression Market Report Highlights

• By expression system, the prokaryotic segment accounted for the largest share in 2022. The high usage of this system among the researchers is due to enabling them to produce biologically active proteins in large quantities in a short time
• By product, the services segment is anticipated to witness lucrative growth over the forecast period. The increasing outsourcing to CROs and growing demand for recombinant protein in the non-healthcare sectors are fueling the segment growth
• By application, the therapeutic segment dominated the market in 2022. This is attributed to an increase in R&D investment and strategic initiatives such as fundraising
• By end-user, the pharmaceutical and biotechnological companies segment held the largest revenue share in 2022 owing to the growing demand for biologics for chronic diseases
• North America dominated the global market in 2022 owing to the availability of funding opportunities for emerging players, along with the existence of significant R&D investment in the region

Table of Contents

Chapter 1. Methodology and Scope

• 1.1 Market Segmentation and Scope
  • 1.1.1 Segment Definitions
    • 1.1.1.1 Expression System Segment
    • 1.1.1.2 Product Segment
    • 1.1.1.3 Application Segment
    • 1.1.1.4 End User Segment
• 1.2 Information Procurement
  • 1.2.1 Market Formulation & Data Visualization
  • 1.2.2 Data Validation & Publishing
• 1.3 Research Assumptions
• 1.4 Research Methodology
  • 1.4.1 Purchased Database
  • 1.4.2 Gvr's Internal Database
  • 1.4.3 Secondary Sources
  • 1.4.5 Primary Research
  • 1.4.6 Details Of Primary Research
• 1.5 Information Or Data Analysis
  • 1.5.1 Data Analysis Models
• 1.6 Market Formulation & Validation
• 1.7 Model Details
  • 1.7.1 Commodity Flow Analysis
    • 1.7.1.1 Approach 1: Commodity flow approach
• 1.8 List of Secondary Sources
• 1.9 Global Market: CAGR Calculation
• 1.10 Objectives

Chapter 2. Executive Summary

• 2.1. Market Snapshot
• 2.2. Segment Snapshot
• 2.3. Competitive Landscape Snapshot

Chapter 3. Protein Expression Market Variables and Trends

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent Market Outlook
  • 3.1.2. Related/Ancillary Market Outlook
• 3.2. Market Dynamics
  • 3.2.1. Market Driver Impact Analysis
    • 3.2.1.1. Escalating Demand For Biologics
    • 3.2.1.2. Increasing Investment In R&D
    • 3.2.1.3. Rising Funding By Government For Proteomics And Genomics Research
  • 3.2.2. Market Restraint Impact Analysis
    • 3.2.2.1. Stringent government rules and regulations
    • 3.2.2.2. Intense competition among vendors
• 3.3. Industry Analysis Tools
  • 3.3.1.1. Porter's Five Forces Analysis
  • 3.3.1.2. PESTEL Analysis
  • 3.3.1.3. COVID-19 Impact Analysis

Chapter 4. Protein Expression System Business Analysis

• 4.1 Protein Expression Market: Expression Systems Movement Analysis
• 4.2 Prokaryotic Expression Systems
  • 4.2.1 Prokaryotic expression systems market, 2018 - 2030 (USD Million)
• 4.3 Mammalian Cell Expression Systems
  • 4.3.1 Mammalian cell expression systems market, 2018 - 2030 (USD Million)
• 4.4 Insect Cell Expression Systems
  • 4.4.1 Insect cell expression systems market, 2018 - 2030 (USD Million)
• 4.5 Yeast Expression Systems
  • 4.5.1 Yeast expression systems market, 2018 - 2030 (USD Million)
• 4.6 Other Expression Systems
  • 4.6.1 Other expression systems market, 2018 - 2030 (USD Million)

Chapter 5. Product Business Analysis

• 5.1 Protein Expression Market: Product Movement Analysis
• 5.2 Reagents
  • 5.2.1 Reagents market, 2018 - 2030 (USD Million)
• 5.3 Competent Cells
  • 5.3.1 Competent cells market, 2018 - 2030 (USD Million)
• 5.4 Expression Vectors
  • 5.4.1 Expression vectors market, 2018 - 2030 (USD Million)
• 5.5 Services
  • 5.5.1 Services market, 2018 - 2030 (USD Million)
• 5.6 Instruments
  • 5.6.1 Instruments market, 2018 - 2030 (USD Million)

Chapter 6. Application Business Analysis

• 6.1 Protein Expression Market: Application Movement Analysis
• 6.2 Therapeutic Applications
  • 6.2.1 Therapeutic applications market, 2018 - 2030 (USD Million)
• 6.3 Industrial Applications
  • 6.3.1 Industrial applications market, 2018 - 2030 (USD Million)
• 6.4 Research Applications
  • 6.4.1 Research applications Market, 2018 - 2030 (USD Million)

Chapter 7. End-use Business Analysis

• 7.1 Protein Expression Market: End-use Movement Analysis
• 7.2 Pharmaceutical and Biotechnological Companies
  • 7.2.1 Pharmaceutical and biotechnological companies market, 2018 - 2030 (USD Million)
• 7.3 Academic Research
  • 7.3.1 Academic research market, 2018 - 2030 (USD Million)
• 7.4 Contract Research Organizations
  • 7.4.1 Contract research organizations market, 2018 - 2030 (USD Million)

Chapter 8. Regional Business Analysis

• 8.1. Protein Expression Market Share By Region, 2022 & 2030
• 8.2. North America
  • 8.2.1. North America Protein Expression Market, 2018 - 2030 (USD Million)
  • 8.2.2. U.S.
    • 8.2.2.1. Key Country Dynamics
    • 8.2.2.2. Target Disease Prevalence
    • 8.2.2.3. Competitive Scenario
    • 8.2.2.4. U.S. Protein Expression Market, 2018 - 2030 (USD Million)
  • 8.2.3. Canada
    • 8.2.3.1. Key Country Dynamics
    • 8.2.3.2. Target Disease Prevalence
    • 8.2.3.3. Competitive Scenario
    • 8.2.3.4. Canada Protein Expression Market, 2018 - 2030 (USD Million)
• 8.3. Europe
  • 8.3.1. Europe Protein Expression Market, 2018 - 2030 (USD Million)
  • 8.3.2. UK
    • 8.3.2.1. Key Country Dynamics
    • 8.3.2.2. Target Disease Prevalence
    • 8.3.2.3. Competitive Scenario
    • 8.3.2.4. UK Protein Expression Market, 2018 - 2030 (USD Million)
  • 8.3.3. Germany
    • 8.3.3.1. Key Country Dynamics
    • 8.3.3.2. Target Disease Prevalence
    • 8.3.3.3. Competitive Scenario
    • 8.3.3.4. Germany Protein Expression Market, 2018 - 2030 (USD Million)
  • 8.3.4. France
    • 8.3.4.1. Key Country Dynamics
    • 8.3.4.2. Target Disease Prevalence
    • 8.3.4.3. Competitive Scenario
    • 8.3.4.4. France Protein Expression Market, 2018 - 2030 (USD Million)
  • 8.3.5. Italy
    • 8.3.5.1. Key Country Dynamics
    • 8.3.5.2. Target Disease Prevalence
    • 8.3.5.3. Competitive Scenario
    • 8.3.5.4. Italy Protein Expression Market, 2018 - 2030 (USD Million)
  • 8.3.6. Spain
    • 8.3.6.1. Key Country Dynamics
    • 8.3.6.2. Target Disease Prevalence
    • 8.3.6.3. Competitive Scenario
    • 8.3.6.4. Spain Protein Expression Market, 2018 - 2030 (USD Million)
  • 8.3.7. Denmark
    • 8.3.7.1. Key Country Dynamics
    • 8.3.7.2. Target Disease Prevalence
    • 8.3.7.3. Competitive Scenario
    • 8.3.7.4. Denmark Protein Expression Market, 2018 - 2030 (USD Million)
  • 8.3.8. Sweden
    • 8.3.8.1. Key Country Dynamics
    • 8.3.8.2. Target Disease Prevalence
    • 8.3.8.3. Competitive Scenario
    • 8.3.8.4. Sweden Protein Expression Market, 2018 - 2030 (USD Million)
  • 8.3.9. Norway
    • 8.3.9.1. Key Country Dynamics
    • 8.3.9.2. Target Disease Prevalence
    • 8.3.9.3. Competitive Scenario
    • 8.3.9.4. Norway Protein Expression Market, 2018 - 2030 (USD Million)
• 8.4. Asia Pacific
  • 8.4.1. Asia Pacific Protein Expression Market, 2018 - 2030 (USD Million)
  • 8.4.2. Japan
    • 8.4.2.1. Key Country Dynamics
    • 8.4.2.2. Target Disease Prevalence
    • 8.4.2.3. Competitive Scenario
    • 8.4.2.4. Japan Protein Expression Market, 2018 - 2030 (USD Million)
  • 8.4.3. China
    • 8.4.3.1. Key Country Dynamics
    • 8.4.3.2. Target Disease Prevalence
    • 8.4.3.3. Competitive Scenario
    • 8.4.3.4. China Protein Expression Market, 2018 - 2030 (USD Million)
  • 8.4.4. India
    • 8.4.4.1. Key Country Dynamics
    • 8.4.4.2. Target Disease Prevalence
    • 8.4.4.3. Competitive Scenario
    • 8.4.4.4. India Protein Expression Market, 2018 - 2030 (USD Million)
  • 8.4.5. Australia
    • 8.4.5.1. Key Country Dynamics
    • 8.4.5.2. Target Disease Prevalence
    • 8.4.5.3. Competitive Scenario
    • 8.4.5.4. Australia Protein Expression Market, 2018 - 2030 (USD Million)
  • 8.4.6. Thailand
    • 8.4.6.1. Key Country Dynamics
    • 8.4.6.2. Target Disease Prevalence
    • 8.4.6.3. Competitive Scenario
    • 8.4.6.4. Thailand Protein Expression Market, 2018 - 2030 (USD Million)
  • 8.4.7. South Korea
    • 8.4.7.1. Key Country Dynamics
    • 8.4.7.2. Target Disease Prevalence
    • 8.4.7.3. Competitive Scenario
    • 8.4.7.4. South Korea Protein Expression Market, 2018 - 2030 (USD Million)
• 8.5. Latin America
  • 8.5.1. Latin America Protein Expression Market, 2018 - 2030 (USD Million)
  • 8.5.2. Brazil
    • 8.5.2.1. Key Country Dynamics
    • 8.5.2.2. Target Disease Prevalence
    • 8.5.2.3. Competitive Scenario
    • 8.5.2.4. Brazil Protein Expression Market, 2018 - 2030 (USD Million)
  • 8.5.3. Mexico
    • 8.5.3.1. Key Country Dynamics
    • 8.5.3.2. Target Disease Prevalence
    • 8.5.3.3. Competitive Scenario
    • 8.5.3.4. Mexico Protein Expression Market, 2018 - 2030 (USD Million)
  • 8.5.4. Argentina
    • 8.5.4.1. Key Country Dynamics
    • 8.5.4.2. Target Disease Prevalence
    • 8.5.4.3. Competitive Scenario
    • 8.5.4.4. Argentina Protein Expression Market, 2018 - 2030 (USD Million)
• 8.6. MEA
  • 8.6.1. MEA Protein Expression Market, 2018 - 2030 (USD Million)
  • 8.6.2. South Africa
    • 8.6.2.1. Key Country Dynamics
    • 8.6.2.2. Target Disease Prevalence
    • 8.6.2.3. Competitive Scenario
    • 8.6.2.4. South Africa Protein Expression Market, 2018 - 2030 (USD Million)
  • 8.6.3. Saudi Arabia
    • 8.6.3.1. Key Country Dynamics
    • 8.6.3.2. Target Disease Prevalence
    • 8.6.3.3. Competitive Scenario
    • 8.6.3.4. Saudi Arabia Protein Expression Market, 2018 - 2030 (USD Million)
  • 8.6.4. UAE
    • 8.6.4.1. Key Country Dynamics
    • 8.6.4.2. Target Disease Prevalence
    • 8.6.4.3. Competitive Scenario
    • 8.6.4.4. UAE Protein Expression Market, 2018 - 2030 (USD Million)
  • 8.6.5. Kuwait
    • 8.6.5.1. Key Country Dynamics
    • 8.6.5.2. Target Disease Prevalence
    • 8.6.5.3. Competitive Scenario
    • 8.6.5.4. Kuwait Protein Expression Market, 2018 - 2030 (USD Million)

Chapter 9. Competitive Landscape

• 9.1. Company Categorization
• 9.2. Strategy Mapping
• 9.3. Company Market Share Analysis, 2022
• 9.4. Company Profiles/Listing
  • 9.4.1. Agilent Technologies, Inc
    • 9.4.1.1. Overview
    • 9.4.1.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
    • 9.4.1.3. Product Benchmarking
    • 9.4.1.4. Strategic Initiatives
  • 9.4.2. QIAGEN
    • 9.4.2.1. Overview
    • 9.4.2.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
    • 9.4.2.3. Product Benchmarking
    • 9.4.2.4. Strategic Initiatives
  • 9.4.3. Thermo Fisher Scientific, Inc.
    • 9.4.3.1. Overview
    • 9.4.3.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
    • 9.4.3.3. Product Benchmarking
    • 9.4.3.4. Strategic Initiatives
  • 9.4.4. Merck KGaA
    • 9.4.4.1. Overview
    • 9.4.4.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
    • 9.4.4.3. Product Benchmarking
    • 9.4.4.4. Strategic Initiatives
  • 9.4.5. Bio-Rad Laboratories, Inc.
    • 9.4.5.1. Overview
    • 9.4.5.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
    • 9.4.5.3. Product Benchmarking
    • 9.4.5.4. Strategic Initiatives
  • 9.4.6. Promega Corporation
    • 9.4.6.1. Overview
    • 9.4.6.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
    • 9.4.6.3. Product Benchmarking
    • 9.4.6.4. Strategic Initiatives
  • 9.4.7. New England Biolabs
    • 9.4.7.1. Overview
    • 9.4.7.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
    • 9.4.7.3. Product Benchmarking
    • 9.4.7.4. Strategic Initiatives
  • 9.4.8. Takara Bio, Inc.
    • 9.4.8.1. Overview
    • 9.4.8.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
    • 9.4.8.3. Product Benchmarking
    • 9.4.8.4. Strategic Initiatives
  • 9.4.9. Oxford Expression Technologies
    • 9.4.9.1. Overview
    • 9.4.9.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
    • 9.4.9.3. Product Benchmarking
    • 9.4.9.4. Strategic Initiatives
  • 9.4.10. Lucigen Corporation
    • 9.4.10.1. Overview
    • 9.4.10.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
    • 9.4.10.3. Product Benchmarking
    • 9.4.10.4. Strategic Initiatives